Navigation Links
VasoNova Inc. Announces Strategic Partnership With Navilyst Medical Inc.
Date:9/24/2010

MENLO PARK, Calif., Sept. 24 /PRNewswire/ -- VasoNova (VasoNova Inc., Menlo Park, California) announced a strategic partnership with Navilyst Medical Inc. (Navilyst Medical Inc., Marlborough, Massachusetts) today to distribute its VasoNova™ Vascular Positioning System™ VPS™ central venous catheter navigation technology.

Commenting on the partnership, Navilyst Senior Vice President, George Bourne said "Navilyst Medical is a market and technology leader in vascular access and fluid management with a long tradition of therapeutic innovation. Accurate catheter tip location is clinically beneficial to the patient and directly contributes to lowering healthcare costs. These two things are firmly aligned with our mission and reflected in our many other market leading innovations in vascular access. We are very excited to be bringing the VasoNova™ VPS™ catheter navigation technology to our customers. The combination of best-in-class central venous catheters from Navilyst and real time catheter tip positioning of this caliber from VasoNova provides the best possible solution to our clinicians and for our patients".    

Paul Molloy, President & Chief Executive Officer at VasoNova added, "VasoNova's VPS™ technology is the first real-time intra-vascular catheter navigation technology that does not require external metal detectors or viewing screens, nor subjective interpretation of ECG signals, and is capable of confirming precise catheter tip location using highly sophisticated anatomical location identification algorithms embedded in its technology. These location signatures are identified utilizing highly specific Doppler ultrasound characteristics combined with other patient data. The VasoNova™ VPS™ is compatible with all commonly used PICC and CVC catheters. Navilyst's world-class vascular access product offering is highly synergistic and together we off
'/>"/>

SOURCE VasoNova Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015  DICOM Grid,  the #1 ... it was recognized as a semifinalist for a ... The awards are sponsored by Auntminnie.com, a ... in the medical imaging industry.  Since 1999, the ... to acknowledge the contributions of their peers. Nominations ...
(Date:8/31/2015)... JERUSALEM, Israel, Aug. 31, 2015  Chiasma, Inc. ... company developing octreotide capsules for the orphan condition ... quarter ended June 30, 2015 and provided a ... have been a transformative time for Chiasma, as ... recently announced that our first New Drug Application ...
(Date:8/31/2015)... Thousands of people will peacefully demonstrate their ... addiction epidemic at dozens of rallies across the country ... the United States has experienced skyrocketing ... and heroin, yet the President has never once spoken ... letter to President Obama , rally organizers compared his ...
Breaking Medicine Technology:DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 2Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 3Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 4Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 5Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 6Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 7Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 8Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 9Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2
(Date:9/1/2015)... ... ... A new episode of “Voices In America”, hosted by famous actor and voice ... There are over 100 different types of arthritis. One of the most popular is ... to shed light on this important topic. , Anyone who is nearing their golden ...
(Date:9/1/2015)... ... 01, 2015 , ... Specialty Technical Publishers (STP) and Specialty ... Consortium (IAPC) EHS audit protocol for the European Union. Leading companies around the ... regulatory obligations and rapidly collect, share, archive, and export audit findings in a ...
(Date:8/31/2015)... ... September 01, 2015 , ... AthleticTraining.com, provider of CEUs for ... of new premium on-demand video Evidence Based Practice courses that ... 2014 must complete 50 CEUs before December 31, 2015, which must include at ...
(Date:8/31/2015)... ... 31, 2015 , ... Jvion, the Atlanta-based leader in predictive ... focused on helping hospital perform under the Center for Medicare & Medicaid Services’ ... based on performance across four domains related to care quality. To receive a ...
(Date:8/31/2015)... ... August 31, 2015 , ... ITC Global Translations website, ... specific translation services within the medical and pharmaceutical industries. These are industries that ... work. , ITC Global Translations specializes in professional translation services for materials used ...
Breaking Medicine News(10 mins):Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 3Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 4Health News:Evidence Based Practice Courses: CEUs For Athletic Trainers Just Released 2Health News:Jvion Releases Value-Based Purchasing Predictive Use Case 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 3
... international team led by University of Calgary researcher Ken Ng ... virus uses to make copies of its genetic code in ... drugs that could be used to treat outbreaks of Norwalk ... the enzyme, RNA polymerase, to make new strands of RNA ...
... March 18 Placing a "super-long coffee order,",a ... now make a,difference for Children,s Hospital and Regional ... will donate $1 to Children,s,Hospital for every Tully,s ... -- those unique concoctions made up of seemingly,incongruous ...
... RxElite, Inc. (OTC,Bulletin Board: RXEI), a developer, manufacturer, ... it will discuss its,2007 year-end financial results in a ... EDT., The Company will release its 2007 year-end ... 2008. Hosting the call will be,RxElite CEO Jonathan Houssian, ...
... 18 /Xinhua-PRNewswire/ -- Chindex International,Inc. (Nasdaq: CHDX ) ... unanimously approved a three-for-two split of all shares of,the ... its Class,B Common Stock. Stockholders of record as of ... one-half additional share of Common Stock for each,share owned ...
... Sigma-Aldrich (Nasdaq:,SIAL) announced today that it has ... facility established in December 2006 by exercising $150,million ... $450 million,revolving credit facility, $30 million will mature ... on December 11, 2012. The facility will provide,back-up ...
... 18 W. Scott Harkonen,M.D., the former CEO ... and,felony Food, Drug and Cosmetic Act charges for ... and misleading information about the efficacy of,InterMune,s drug ... fibrosis (IPF), the Justice Department announced,today., The ...
Cached Medicine News:Health News:Scientists see Norwalk virus' Achilles heel 2Health News:PEMCO Insurance and Tully's Coffee Team Up to Make Coffee Orders Count - For Children's Hospital 2Health News:PEMCO Insurance and Tully's Coffee Team Up to Make Coffee Orders Count - For Children's Hospital 3Health News:RxElite Inc. Fourth Quarter and Year-End 2007 Earnings Release and Conference Call Notice 2Health News:Chindex International, Inc. Announces Three-For-Two Stock Split 2Health News:Chindex International, Inc. Announces Three-For-Two Stock Split 3Health News:Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations 2Health News:Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations 3Health News:Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations 4
This is an Immunological assay intended for the quantitative in vitro determination of haemoglobin A1c (HbA1c) in whole blood....
For the quantitative in vitro determination of Potassium in serum or plasma....
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
For the quantitative in vitro determination of Valproic Acid in human serum...
Medicine Products: